These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38151214)

  • 1. Serum peroxiredoxin-4, a biomarker of oxidative stress, is associated with the development of nephropathy in patients with type 2 diabetes (Zodiac-65).
    Bourgonje AR; van Goor H; Bakker SJL; Hillebrands JL; Bilo HJG; Dullaart RPF; van Dijk PR
    Free Radic Biol Med; 2024 Feb; 212():186-190. PubMed ID: 38151214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of GlycA, a pro-inflammatory glycoprotein biomarker, associate with an increased risk of microvascular complications in patients with type 2 diabetes (Zodiac-62).
    Bourgonje AR; van der Vaart A; Gruppen EG; van Goor H; Bakker SJL; Connelly MA; van Dijk PR; Dullaart RPF
    Endocrine; 2023 May; 80(2):312-316. PubMed ID: 36757630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63).
    Bourgonje AR; Connelly MA; van Goor H; van Dijk PR; Dullaart RPF
    Cardiovasc Diabetol; 2023 Jul; 22(1):169. PubMed ID: 37415152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28).
    Gerrits EG; Alkhalaf A; Landman GW; van Hateren KJ; Groenier KH; Struck J; Schulte J; Gans RO; Bakker SJ; Kleefstra N; Bilo HJ
    PLoS One; 2014; 9(2):e89719. PubMed ID: 24586984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum high-sensitivity C-reactive protein levels are associated with high risk of development, not progression, of diabetic nephropathy among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT7]).
    Hayashino Y; Mashitani T; Tsujii S; Ishii H;
    Diabetes Care; 2014 Nov; 37(11):2947-52. PubMed ID: 25168126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30).
    Landman GW; van Dijk PR; Drion I; van Hateren KJ; Struck J; Groenier KH; Gans RO; Bilo HJ; Bakker SJ; Kleefstra N
    Diabetes Care; 2014; 37(3):839-45. PubMed ID: 24170764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Landman GW; Kleefstra N; Groenier KH; Bakker SJ; Groeneveld GH; Bilo HJ; van Hateren KJ
    Atherosclerosis; 2016 Jul; 250():46-51. PubMed ID: 27179179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes.
    Odegaard AO; Jacobs DR; Sanchez OA; Goff DC; Reiner AP; Gross MD
    Cardiovasc Diabetol; 2016 Mar; 15():51. PubMed ID: 27013319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Citrate Levels Are Associated with an Increased Risk of Cardiovascular Mortality in Patients with Type 2 Diabetes (Zodiac-64).
    Bourgonje AR; Connelly MA; van Goor H; van Dijk PR; Dullaart RPF
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study.
    Aryan Z; Ghajar A; Faghihi-Kashani S; Afarideh M; Nakhjavani M; Esteghamati A
    Ann Nutr Metab; 2018; 72(4):287-295. PubMed ID: 29694948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
    Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
    Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein partially mediates the inverse association between coffee consumption and risk of type 2 diabetes: The UK Biobank and the Rotterdam study cohorts.
    Ochoa-Rosales C; van der Schaft N; Braun KVE; Ho FK; Petermann-Rocha F; Ahmadizar F; Kavousi M; Pell JP; Ikram MA; Celis-Morales CA; Voortman T
    Clin Nutr; 2023 May; 42(5):661-669. PubMed ID: 36940600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Walking pace and microvascular complications among individuals with type 2 diabetes: A cohort study from the UK Biobank.
    Zhu X; Zhang X; Zhou C; Li B; Huang Y; Li C; Gu C; Ma M; Zhao S; Fan Y; Xu X; Chang J; Chen H; Zheng Z
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14501. PubMed ID: 37740713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.
    Abbasi A; Corpeleijn E; Postmus D; Gansevoort RT; de Jong PE; Gans RO; Struck J; Schulte J; Hillege HL; van der Harst P; Peelen LM; Beulens JW; Stolk RP; Navis G; Bakker SJ
    J Am Heart Assoc; 2012 Oct; 1(5):e002956. PubMed ID: 23316297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitive C-reactive protein and risk of incident type 2 diabetes: a case-control study nested within the Singapore Chinese Health Study.
    Pan A; Wang Y; Yuan JM; Koh WP
    BMC Endocr Disord; 2017 Feb; 17(1):8. PubMed ID: 28178951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between circulating inflammatory markers, diabetes type and complications in youth.
    Aulich J; Cho YH; Januszewski AS; Craig ME; Selvadurai H; Wiegand S; Jenkins AJ; Donaghue KC
    Pediatr Diabetes; 2019 Dec; 20(8):1118-1127. PubMed ID: 31464058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between spirometric impairments and microvascular complications in type 2 diabetes: a cross-sectional study.
    Hayfron-Benjamin CF; Agyemang C; van den Born BH; Amoah AGB; Amissah-Arthur KN; Musah L; Abaidoo B; Awula P; Awuviri HW; Abbey JA; Fummey DA; Ackam JN; Asante GO; Hashimoto S; Maitland-van der Zee AH
    BMJ Open; 2023 Oct; 13(10):e075209. PubMed ID: 37903605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus.
    Streja D; Cressey P; Rabkin SW
    J Diabetes Complications; 2003; 17(3):120-7. PubMed ID: 12738395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.